Table 1.
List of direct‐acting antivirals
| Direct‐acting antiviral agents (DAAs) | |||
| NS3/NS4A inhibitors | NS5B inhibitors | NS5A inhibitors | |
| NPI | NNPI | ||
| ACH‐2684 | ALS2200/VX135 | ABT‐072 | ACH‐2928 |
| Asunaprevir | BILB1941 | Beclabuvir | Daclatasvir |
| Boceprevir | GS0938/PSI352938 | BI201127 | Elbasvir |
| Celuprevir | GS6620 | Dasabuvir | GSK2336805 |
| Danoprevir | GS9851(PSI7851) | Deleobuvir | Ledipasvir |
| Faldaprevir | IDX184 | Filibuvir | MK‐8408 |
| Grazoprevir | INX189/BMS986094 | GSK2878175/GSK175 | Odalasvir |
| GS9256 | Mericitabine | IDX375 | Ombitasvir |
| GS9857 | MK‐3682 | MK‐3281 | PPI461 |
| IDX320 | Sofosbuvir | Nesbuvir | Ravidasvir |
| Narlaprevir | VX‐135 | Radalbuvir | Samatasvir |
| Paritaprevir | ‐ | Setrobuvir | Velpatasvir |
| PHX1766 | ‐ | Tegobuvir | ‐ |
| Simperevir | ‐ | TMC‐647055 | ‐ |
| Sovaprevir | ‐ | VCH‐759 | ‐ |
| Telaprevir | ‐ | VCH‐916 | ‐ |
| Vaniprevir | ‐ | VX222 | ‐ |
| Vedroprevir | ‐ | ‐ | ‐ |
The table presents a list of 58 direct‐acting antiviral agents (DAAs). We have listed the DAAs according to the DAA class they belong to (see Background section). When a DAA has not been assigned a generic or brand name, we have presented it with its experimental compound number prefix.